Development and characterization of transdermal patches using novel thymoquinone-L-arginine-based polyamide nanocapsules for potential use in the management of psoriasis

Eman Dahmash; Lama Murad Attiany; Dalia Ali; Shereen M. Assaf; Jamal Alkrad; Hamad Alyami

doi:10.1208/s12249-024-02781-2

Development and characterization of transdermal patches using novel thymoquinone-L-arginine-based polyamide nanocapsules for potential use in the management of psoriasis

Eman Dahmash, Lama Murad Attiany, Dalia Ali, Shereen M. Assaf, Jamal Alkrad, Hamad Alyami

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	AAPS PharmSciTech
Volume	25
Issue number	4
DOIs	https://doi.org/10.1208/s12249-024-02781-2
Publication status	Published - 27 Mar 2024

Keywords

Pharmacy

Access to Document

10.1208/s12249-024-02781-2

https://doi.org/10.1208/s12249-024-02781-2

Cite this

@article{6b0cffe033c441a4a9a5fb285a32da91,

title = "Development and characterization of transdermal patches using novel thymoquinone-L-arginine-based polyamide nanocapsules for potential use in the management of psoriasis",

keywords = "Pharmacy",

author = "Eman Dahmash and Attiany, \{Lama Murad\} and Dalia Ali and Assaf, \{Shereen M.\} and Jamal Alkrad and Hamad Alyami",

year = "2024",

month = mar,

day = "27",

doi = "10.1208/s12249-024-02781-2",

language = "English",

volume = "25",

journal = "AAPS PharmSciTech",

issn = "1530-9932",

publisher = "Springer International Publishing AG",

number = "4",

}

TY - JOUR

T1 - Development and characterization of transdermal patches using novel thymoquinone-L-arginine-based polyamide nanocapsules for potential use in the management of psoriasis

AU - Dahmash, Eman

AU - Attiany, Lama Murad

AU - Ali, Dalia

AU - Assaf, Shereen M.

AU - Alkrad, Jamal

AU - Alyami, Hamad

PY - 2024/3/27

Y1 - 2024/3/27

KW - Pharmacy

U2 - 10.1208/s12249-024-02781-2

DO - 10.1208/s12249-024-02781-2

M3 - Article

SN - 1530-9932

VL - 25

JO - AAPS PharmSciTech

JF - AAPS PharmSciTech

IS - 4

ER -